Crucible · Firm report card

Vertex Pharmaceuticals Inc.

MA · SBIR awardee across 2 federal programs (NSF, HHS/NIH), first award 1990.

7SBIR awards

$1MSBIR $

5 → 2Phase I → II

$0Follow-on federal $

0Follow-on contracts

SBIR awards by program

Program	Awards	SBIR $	Phase I	Phase II
NSF	2	$349,556	1	1
HHS/NIH	5	$699,780	4	1

Mission areas

Chemistry & Chemical Processes
Drug Discovery & Delivery
Genomics & Cell Therapy
Infectious Disease & Vaccines

Open the interactive profile of Vertex Pharmaceuticals Inc. →

Full award history, follow-on contract detail, and cross-agency comparison in the Crucible app.

Data: SBIR.gov award records + USAspending.gov prime contracts, matched by recipient name. Follow-on dollars are association, not causation — they show where this firm's later federal prime-contract dollars landed, not that SBIR work caused them. Methodology